Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.

Suppr

超能文献

作者信息

Patel Amit, Waheed Umeer, Brett Stephen J

出版信息

Intensive Care Med. 2013 Aug;39(8):1507-8. doi: 10.1007/s00134-013-2962-4. Epub 2013 Jun 5.

DOI:10.1007/s00134-013-2962-4

PMID:23736140

Abstract

摘要

相似文献

Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.

Intensive Care Med. 2013 Aug;39(8):1507-8. doi: 10.1007/s00134-013-2962-4. Epub 2013 Jun 5.

Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis.严重脓毒症 6% 琥珀明胶（羟乙基淀粉 130/0.4 或 0.42）随机试验报告死亡率：系统评价和荟萃分析。

Intensive Care Med. 2013 May;39(5):811-22. doi: 10.1007/s00134-013-2863-6. Epub 2013 Feb 22.

"Colloid twice daily" is not fluid resuscitation! Inappropriate inclusion of clinical trials in meta-analyses may distract from gaps in evidence.“每日两次胶体液”并非液体复苏！在荟萃分析中不恰当地纳入临床试验可能会掩盖证据方面的差距。

Intensive Care Med. 2013 Aug;39(8):1503. doi: 10.1007/s00134-013-2954-4. Epub 2013 Jun 5.

Is the literature inconclusive about the harm from HES? No.关于羟乙基淀粉的危害，文献尚无定论吗？并非如此。

Intensive Care Med. 2017 Oct;43(10):1523-1525. doi: 10.1007/s00134-016-4275-x. Epub 2016 Mar 23.

Hydroxyethyl starch for resuscitation.羟乙基淀粉复苏。

Curr Opin Crit Care. 2013 Aug;19(4):321-5. doi: 10.1097/MCC.0b013e3283632de6.

Tetrastarch solutions: are they definitely dead?羟乙基淀粉溶液：它们肯定不行了吗？

Br J Anaesth. 2013 Sep;111(3):324-7. doi: 10.1093/bja/aet300.

Is 6% tetrastarch 130kDa (hydroxyethyl starch 130/0.4 or 130/0.42) suitable for severe sepsis?6% 130kDa 四淀粉（羟乙基淀粉130/0.4或130/0.42）适用于严重脓毒症吗？

Br J Hosp Med (Lond). 2013 Mar;74(3):178. doi: 10.12968/hmed.2013.74.3.178.

Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.羟乙基淀粉作为严重脓毒症急性肾衰竭的一个危险因素。

Lancet. 2001 Aug 18;358(9281):581; author reply 582. doi: 10.1016/S0140-6736(01)05718-X.

Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.羟乙基淀粉作为严重脓毒症急性肾衰竭的一个危险因素。

Lancet. 2001 Aug 18;358(9281):581; author reply 582. doi: 10.1016/S0140-6736(01)05719-1.

Is the literature inconclusive about the harm from HES? Yes.关于羟乙基淀粉的危害，文献是否尚无定论？是的。

Intensive Care Med. 2017 Oct;43(10):1520-1522. doi: 10.1007/s00134-016-4278-7. Epub 2016 Mar 23.

本文引用的文献

Intensive Care Med. 2013 Aug;39(8):1503. doi: 10.1007/s00134-013-2954-4. Epub 2013 Jun 5.

Intensive Care Med. 2013 May;39(5):811-22. doi: 10.1007/s00134-013-2863-6. Epub 2013 Feb 22.

Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.羟乙基淀粉给药与需要容量复苏的危重症患者死亡率和急性肾损伤的关系：系统评价和荟萃分析。

JAMA. 2013 Feb 20;309(7):678-88. doi: 10.1001/jama.2013.430.

Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis.羟乙基淀粉 130/0.38-0.45 与晶体或白蛋白在脓毒症患者中的比较：系统评价与荟萃分析和试验序贯分析。

BMJ. 2013 Feb 15;346:f839. doi: 10.1136/bmj.f839.

Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy.急性病患者中用 6%羟乙基淀粉（130/0.4 和 130/0.42）进行液体复苏：对死亡率和肾脏替代治疗影响的系统评价。

Intensive Care Med. 2013 Apr;39(4):558-68. doi: 10.1007/s00134-013-2840-0. Epub 2013 Feb 14.

Therapeutic influence of 20 % albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial.20%白蛋白与6%羟乙基淀粉对脓毒症患者血管外肺水的治疗影响：一项随机对照试验

Hepatogastroenterology. 2009 Nov-Dec;56(96):1622-8.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验